Kimberly Harrington
About Kimberly Harrington
Kimberly Harrington is a Senior Scientist at Bristol Myers Squibb in Seattle, Washington, specializing in multi-color flow cytometry and lentiviral transductions.
Current Position at Bristol Myers Squibb
Kimberly Harrington is a Senior Scientist at Bristol Myers Squibb, based in Seattle, Washington. In her role, she leads a team focused on the development of clinical candidate CAR T cells. Her responsibilities also include assisting with Investigational New Drug (IND) filings, preparing technical reports, and setting project timelines.
Previous Roles at Bristol Myers Squibb
Before her current position, Kimberly Harrington worked as a Scientist at Bristol Myers Squibb for seven months from 2020 to 2021. During this time, she contributed significantly to research initiatives geared towards the development of CAR T cells and lentiviral transductions.
Experience at Juno Therapeutics, Inc.
Kimberly Harrington served as a Senior Associate Scientist at Juno Therapeutics, Inc. from 2016 to 2020. Over these four years, she specialized in multi-color flow cytometry and made substantial contributions to the company’s research and development efforts.
Tenure at Fred Hutch
From 2007 to 2016, Kimberly Harrington was a Research Technician III at Fred Hutch in Seattle, WA. During her nine-year tenure, she gained significant expertise and contributed to various research projects, further cementing her position in the scientific community.
Educational Background at Tufts University
Kimberly Harrington earned her Bachelor's degree in Biology/Biological Sciences, General, from Tufts University, attending from 2003 to 2007. Her academic foundation in biological sciences has been instrumental throughout her professional career.